通化金马：公司研制的琥珀八氢氨吖啶片已完成各项专业审评工作，进入了综合审评环节

Group 1 - The company has completed all professional review work for its innovative Class 1 drug and has entered the comprehensive review stage, indicating it is nearing approval [2] - The specific drug in question is the chemical Class 1 new drug, Amber Dihydroaminoacridine Tablets, which is currently undergoing normal review processes [2] - The company will disclose relevant information about the new drug according to regulations and requirements, urging investors to pay attention to company announcements [2]